|
Activation of ATR in response to replication stress |
|
|
Activation of NF-kappaB in B cells |
|
|
Activation of the pre-replicative complex |
|
|
AKT phosphorylates targets in the cytosol |
|
|
APC truncation mutants have impaired AXIN binding |
|
|
AXIN missense mutants destabilize the destruction complex |
|
|
Beta-catenin phosphorylation cascade |
|
|
CDK-mediated phosphorylation and removal of Cdc6 |
|
|
Constitutive PI3K/AKT Signaling in Cancer |
|
|
CRMPs in Sema3A signaling |
|
|
Cyclin A/B1 associated events during G2/M transition |
|
|
Cyclin A:Cdk2-associated events at S phase entry |
|
|
Cyclin D associated events in G1 |
|
|
Cyclin E associated events during G1/S transition |
|
|
Degradation of beta-catenin by the destruction complex |
|
|
Depolymerisation of the Nuclear Lamina |
|
|
disassembly of the destruction complex and recruitment of AXIN to the membrane |
|
|
Disinhibition of SNARE formation |
|
|
DNA Damage/Telomere Stress Induced Senescence |
|
|
Downregulation of TGF-beta receptor signaling |
|
|
Factors involved in megakaryocyte development and platelet production |
|
|
G alpha (z) signalling events |
|
|
G0 and Early G1 |
|
|
G2 Phase |
|
|
Meiotic recombination |
|
|
misspliced GSK3beta mutants stabilize beta-catenin |
|
|
Oncogene Induced Senescence |
|
|
Orc1 removal from chromatin |
|
|
Oxidative Stress Induced Senescence |
|
|
p53-Dependent G1 DNA Damage Response |
|
|
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 |
|
|
Regulation of APC/C activators between G1/S and early anaphase |
|
|
Regulation of HSF1-mediated heat shock response |
|
|
Regulation of pyruvate dehydrogenase (PDH) complex |
|
|
Response to elevated platelet cytosolic Ca2+ |
|
|
RMTs methylate histone arginines |
|
|
S33 mutants of beta-catenin aren't phosphorylated |
|
|
S37 mutants of beta-catenin aren't phosphorylated |
|
|
S45 mutants of beta-catenin aren't phosphorylated |
|
|
SCF(Skp2)-mediated degradation of p27/p21 |
|
|
Senescence-Associated Secretory Phenotype (SASP) |
|
|
SMAD2/3 MH2 Domain Mutants in Cancer |
|
|
SMAD2/3 Phosphorylation Motif Mutants in Cancer |
|
|
T41 mutants of beta-catenin aren't phosphorylated |
|
|
TGF-beta receptor signaling activates SMADs |
|
|
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
|
|
TGFBR1 KD Mutants in Cancer |
|
|
TGFBR1 LBD Mutants in Cancer |
|
|
TGFBR2 Kinase Domain Mutants in Cancer |
|
|
TGFBR2 MSI Frameshift Mutants in Cancer |
|
|
Trafficking of GluR2-containing AMPA receptors |
|
|
Transcriptional regulation of white adipocyte differentiation |
|
|
truncations of AMER1 destabilize the destruction complex |
|
|
Ubiquitin-dependent degradation of Cyclin D1 |
|
|
VEGFR2 mediated cell proliferation |
|
|
WNT5A-dependent internalization of FZD4 |
|
|
XBP1(S) activates chaperone genes |
|